NRX Pharmaceuticals Inc (NASDAQ: NRXP) closed the day trading at $0.46 up 6.83% from the previous closing price of $0.43. In other words, the price has increased by $+0.0291 from its previous closing price. On the day, 946599 shares were traded.
Ratios:
For a better understanding of NRXP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 0.68.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’23 when Hurvitz Chaim bought 70,000 shares for $0.29 per share. The transaction valued at 20,125 led to the insider holds 570,000 shares of the business.
Gorovitz Aaron bought 35,000 shares of NRXP for $11,196 on Aug 30 ’23. The Director now owns 105,000 shares after completing the transaction at $0.32 per share. On Aug 23 ’23, another insider, Javitt Jonathan C, who serves as the Chief Scientist of the company, bought 100,000 shares for $0.33 each. As a result, the insider paid 33,000 and bolstered with 446,332 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 42.06M and an Enterprise Value of 43.23M.
Stock Price History:
Over the past 52 weeks, NRXP has reached a high of $1.20, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 0.4506, while the 200-Day Moving Average is calculated to be 0.3873.
Shares Statistics:
Over the past 3-months, NRXP traded about 1.85M shares per day on average, while over the past 10 days, NRXP traded about 3.95M shares per day. A total of 66.44M shares are outstanding, with a floating share count of 61.08M. Insiders hold about 33.38% of the company’s shares, while institutions hold 4.34% stake in the company. Shares short for NRXP as of Feb 29, 2024 were 2.71M with a Short Ratio of 1.47, compared to 2.87M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.96% and a Short% of Float of 4.27%.
Earnings Estimates
Current recommendations for the stock of the company come from 3 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.08, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.02 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.28 and -$0.42 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.26, with 3 analysts recommending between -$0.05 and -$0.4.
